BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15957332)

  • 1. Deadly perfectionism?
    Healy B
    US News World Rep; 2005 May; 138(20):50. PubMed ID: 15957332
    [No Abstract]   [Full Text] [Related]  

  • 2. OvaCheck: doubts voiced soon after publication.
    Diamandis EP
    Nature; 2004 Aug; 430(7000):611. PubMed ID: 15295572
    [No Abstract]   [Full Text] [Related]  

  • 3. Proteomics and cancer: running before we can walk?
    Check E
    Nature; 2004 Jun; 429(6991):496-7. PubMed ID: 15175721
    [No Abstract]   [Full Text] [Related]  

  • 4. OvaCheck: let's not dismiss the concept.
    Villanueva J; Tempst P
    Nature; 2004 Aug; 430(7000):611. PubMed ID: 15295571
    [No Abstract]   [Full Text] [Related]  

  • 5. Proteomic diagnostics tested.
    Nature; 2004 Jun; 429(6991):487. PubMed ID: 15175709
    [No Abstract]   [Full Text] [Related]  

  • 6. Battery of routine preoperative tests no longer recommended.
    Schwanitz LD
    OR Manager; 1994 Sep; 10(9):14-5, 18-9. PubMed ID: 10137252
    [No Abstract]   [Full Text] [Related]  

  • 7. A recipe for proteomics diagnostic test development: the OVA1 test, from biomarker discovery to FDA clearance.
    Fung ET
    Clin Chem; 2010 Feb; 56(2):327-9. PubMed ID: 20110452
    [No Abstract]   [Full Text] [Related]  

  • 8. How to improve the quality of waived tests.
    Mitchell B; Murray C
    Fam Pract Manag; 2006 Oct; 13(9):49-52. PubMed ID: 17076111
    [No Abstract]   [Full Text] [Related]  

  • 9. The quest for ovarian cancer's Holy Grail: can CA-125 still be the chalice of early detection?
    Karlan BY; McIntosh M
    J Clin Oncol; 2007 Apr; 25(11):1303-4. PubMed ID: 17416848
    [No Abstract]   [Full Text] [Related]  

  • 10. Early testing still neglected.
    Thomas P
    Med World News; 1988 Aug; 29(15):21. PubMed ID: 10288275
    [No Abstract]   [Full Text] [Related]  

  • 11. Ca screening: auditing the payoff.
    Trubo R
    Med World News; 1985 Nov; 26(22):42-6, 51, 54-5. PubMed ID: 10311354
    [No Abstract]   [Full Text] [Related]  

  • 12. Neglected tests for neglected patients.
    Usdin M; Guillerm M; Chirac P
    Nature; 2006 May; 441(7091):283-4. PubMed ID: 16710396
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use.
    Coates RJ; Kolor K; Stewart SL; Richardson LC
    Clin Cancer Res; 2008 Nov; 14(22):7575-6; author reply 7577-9. PubMed ID: 18948387
    [No Abstract]   [Full Text] [Related]  

  • 14. Myth: early detection is good for everyone.
    Canadian Health Services Research Foundation
    J Health Serv Res Policy; 2007 Apr; 12(2):125-6. PubMed ID: 17407666
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnostic sweat testing: the Cystic Fibrosis Foundation guidelines.
    LeGrys VA; Yankaskas JR; Quittell LM; Marshall BC; Mogayzel PJ;
    J Pediatr; 2007 Jul; 151(1):85-9. PubMed ID: 17586196
    [No Abstract]   [Full Text] [Related]  

  • 16. The medical-surgical nurse's guide to ovarian cancer: part I.
    Bohnenkamp S; LeBaron V; Yoder LH
    Medsurg Nurs; 2007 Aug; 16(4):259-66; quiz 267. PubMed ID: 17907699
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of early diagnosis in managing ovarian cancer.
    Dunleavey R
    Nurs Times; 2006 Oct 10-16; 102(41):28-9. PubMed ID: 17059048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of cancer screening.
    Collins LG; Wynn DT; Barash JH
    Prim Care; 2009 Sep; 36(3):623-39. PubMed ID: 19616158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of ovarian cancer.
    Barber HR
    Compr Ther; 1980 Oct; 6(10):26-33. PubMed ID: 7449361
    [No Abstract]   [Full Text] [Related]  

  • 20. X-rays for childbirth: risky, costly, not always helpful.
    Smith R
    FDA Consum; 1982 Feb; 16(1):20-2. PubMed ID: 10309548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.